Match the bold specific genetic metabolic disorders to their category: adrenal hyperplasia Albinism Cystinuria Galactosaemia Phenylketonuria Pompe Wilson Disease Chromosomal abnormality Excessive amounts of metabolites in a metabolic pathway Storage disease Disrupted regulatory system Disrupted Vitamin and/or co-factor absorption or processing Transport disorder Accumulation of substrates in a metabolic pathway Absence of end product

Match the bold specific genetic metabolic disorders to their category: adrenal hyperplasia Albinism Cystinuria Galactosaemia Phenylketonuria Pompe Wilson Disease Chromosomal abnormality Excessive amounts of metabolites in a metabolic pathway Storage disease Disrupted regulatory system Disrupted Vitamin and/or co-factor absorption or processing Transport disorder Accumulation of substrates in a metabolic pathway Absence of end product

Nutrition Now

8th Edition

ISBN:9781337415408

Author:Brown

Publisher:Brown

Chapter20: Vitamins And Your Health

Section: Chapter Questions

Problem 12RQ

See similar textbooks

Similar questions

Indicate what will happen (increase, decrease or no effect) to the activity of enzyme or rate of the metabolic pathway given the following conditions: 1. epinephrine to the activity of glycogen synthase 2. high [2-carboxyarabinitol-1-phosphate] to the carboxylase activity of RuBisCO
Define the following terms:a. l-amino acid oxidaseb. serine dehydratasec. bacterial ureased. adenosine deaminasee. glutaminase
Make a summary of metabolic disorders arising from carbohydrate metabolism. Indicate the enzyme whose absence or deficiency brings about the disorder.
Explain why the symptoms of a partial defi ciency in a urea cycle enzyme can be attenuated by a low-protein diet.
Indicate whether the following sentences is True or False: During prolonged starvation or in uncontrolled diabetes mellitus, the formation of acetyl-CoA exceeds oxaloacetate supply, forming ketone bodies Hypoglycaemia may be observed in Cushing syndrome patients The range of albuminuria that is considered as a reversible and treatable is 30 – 300 mg/24hr (20 – 200 μg/min) Urea is the major nitrogen-containing metabolic product of protein catabolism in humans, accounting for > 75% of the nonprotein nitrogen eventually excreted GLUT5 is found in small intestine and other organs to transport fructose
Indicate what will happen (increase, decrease or no effect) to the activity of enzyme or rate of the metabolic pathway given the following conditions: 1. release of glucagon in the blood to the activity of carnitine acyl transferase 1 2. phosphorylation of acetyl CoA carboxylase 3. low [carbon dioxide]/[oxygen gas] ratio to the oxygenase activity of RuBisCO
identify one Glycogen storage diseases and explain the pathway affected
Metabolic disorders are due to a LACK OF A PARTICULAR ENZYME OR ONE THAT is defective. Select a metabolis disorder/disease Describe the defect, identifying the enzyme(s) and discuss the therapy available treatment. Does the therapy treat the symptoms or the meatbolic nature of the disease? Explain.
Define the following terms: a. ketogenic amino acid b. glucogenic amino acid c. L-amino acid oxidase d. Krebs urea cycle e. CPSI
Define the following terms:a. Cori cycleb. glucagonc. glucose-alanine cycled. hypoglycemiae. antioxidant
Indicate what will happen (increase, decrease or no effect) to the activity of the enzyme or rate of the metabolic pathway given the following conditions.
A child exhibits clear symptoms during infections or after vigorous exercise indicating hypoglycemia (low blood sugar) as well as increased levels of lactic acid in the blood, and may initially show as shakiness, irritability or even lethargy. The child has a diet similar to other children, so that is not the problem; however, it is noted that diet supplementation with the amino acid alanine is an effective treatment when symptoms show. A) Explain at least two possible metabolic rationales including what and how enzymes might be affected and their metabolic and physiological effects producing this individual’s condition. B) Impressed by your response, your employer holds in her hands DNA sequencing results characterizing a mutation explaining the next case. This case involves an individual who is constantly depleting their glycogen stores, and the mutation is located in the gene encoding glycogen phosphorylase (only isozyme expressed) and the mutation results in an amino acid…